BRPI0113247E2 - composition and method for the treatment of skin disorders in a human - Google Patents
composition and method for the treatment of skin disorders in a humanInfo
- Publication number
- BRPI0113247E2 BRPI0113247E2 BRPI0113247A BRPI0113247E2 BR PI0113247 E2 BRPI0113247 E2 BR PI0113247E2 BR PI0113247 A BRPI0113247 A BR PI0113247A BR PI0113247 E2 BRPI0113247 E2 BR PI0113247E2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- human
- treatment
- skin disorders
- preservative
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
COMPOSIÇçO E METODO PARA O TRATAMENTO DE DESORDENS DA PELE EM UM SER HUMANO. É provida uma composição que possui uma viscosidade de menos do que 15.000 cP para o tratamento de uma desordem de pele num ser humano. A composição consiste essencialmente de: (a) um teor terapeuticamente eficaz furoato de mometasona, (b) um ácido policrilico levemente reticulado, farmaceutimente aceitável, compatível com o composto, (c) uma base farmaceuticamente aceitável para ajustar o pH, (d) pelo menos um solvente miscível em água, (e) opcinalmente um conservante ou uma combinação de mais do que um conservante, (f) pelo menos um tensoativo em combinação com uma fase oleosa, suficiente para formar uma loção, e (g) água. A composição de baixa viscosidade possuí a vantagem de ser administrada mais acuradamente quando combinada com um recipiente que administra a composição em gotas.COMPOSITION AND METHOD FOR TREATMENT OF SKIN DISORDERS IN A HUMAN BEING. A composition having a viscosity of less than 15,000 cP is provided for treating a skin disorder in a human. The composition essentially consists of: (a) a therapeutically effective mometasone furoate content, (b) a pharmaceutically acceptable, slightly cross-linked polycrylic acid compatible with the compound, (c) a pharmaceutically acceptable base for adjusting the pH, (d) at least at least one water-miscible solvent, (e) optionally a preservative or a combination of more than one preservative, (f) at least one surfactant in combination with an oil phase sufficient to form a lotion, and (g) water. The low viscosity composition has the advantage that it is administered more accurately when combined with a container that delivers the droplet composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0113247 BRPI0113247E2 (en) | 2009-04-28 | 2009-04-28 | composition and method for the treatment of skin disorders in a human |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0113247 BRPI0113247E2 (en) | 2009-04-28 | 2009-04-28 | composition and method for the treatment of skin disorders in a human |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0113247E2 true BRPI0113247E2 (en) | 2010-12-14 |
Family
ID=43332439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0113247 BRPI0113247E2 (en) | 2009-04-28 | 2009-04-28 | composition and method for the treatment of skin disorders in a human |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0113247E2 (en) |
-
2009
- 2009-04-28 BR BRPI0113247 patent/BRPI0113247E2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0113247A (en) | Composition, method for the treatment of skin disorders in a human, method for the preparation of a composition | |
CL2017002939A1 (en) | Topical pharmaceutical compositions | |
BR112014010275A2 (en) | diabetes treatment formulations | |
BR112015001419A2 (en) | compound, pharmaceutical composition, and methods for inhibiting romk in a patient, causing diuresis, natriuresis, or both, and for treating one or more disorders. | |
BRPI0822162B8 (en) | pharmaceutical composition for topical treatment of nail disease or nail bed | |
ECSP10010589A (en) | PHARMACO AGAINST LIVER CANCER | |
WO2012136969A3 (en) | Ophthalmic treatments | |
MX2021000376A (en) | Pain-relieving topical compositions. | |
EA201070940A1 (en) | LIQUID DOSAGE FORM FSH | |
BRPI0510760A (en) | method for administering to a patient a composition, topical composition, and patch | |
BR112015005339A8 (en) | use of miracle fruit seed oil as an active ingredient | |
MX338746B (en) | Vitamin d3 and analogs thereof for treating alopecia. | |
WO2009022338A3 (en) | Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications | |
EP2275104A3 (en) | Pharmaceutical and cosmetic composition including lactoferrin, ciclopirox and etidronic acid | |
PL2033635T3 (en) | Use of phenylbutyric acid or salts thereof for treating pruritus | |
NZ589971A (en) | Emollient composition comprising glycerol, vaseline and liquid paraffin | |
BR112019003136A2 (en) | multi-unit dosage form of pharmaceutical composition, unit dosage form of pharmaceutical composition, multi-unit / unit dosage form, kit and method of treating a condition treatable by oral administration of a therapeutically active agent | |
EA201291335A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR LOCAL APPLICATION | |
BR112015001627A2 (en) | pharmaceutical composition, their uses and method of decreasing the frequency of urination | |
BR112014030288A2 (en) | pharmaceutical composition | |
BRPI0113247E2 (en) | composition and method for the treatment of skin disorders in a human | |
WO2015100348A8 (en) | Keloid reduction using topical allantoin | |
RU2015145451A (en) | PRODUCTS FOR LOCAL USE CONTAINING HYALURONIC ACID, VERBASCOZIDE AND GLYCEROPHOSPHOINOSITOL | |
BR112015018144A8 (en) | stable water / pharmaceutical oil emulsion composition with gauge oil droplets, method for making the same high single dose of clopidogrel used to treat a patient | |
EP2514409A1 (en) | Topical pharmaceutical compositions of nimesulide and methylsulfonylmethane |